Germany
· Delayed Price · Currency is EUR Arzneiwerk AG VIDA Statistics
Total Valuation
Arzneiwerk AG VIDA has a market cap or net worth of EUR 4.21 million. The enterprise value is 14.74 million.
| Market Cap | 4.21M |
| Enterprise Value | 14.74M |
Important Dates
The last earnings date was Monday, November 25, 2024.
| Earnings Date | Nov 25, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 2.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.70 |
| EV / Sales | 0.25 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.72 |
Financial Position
The company has a current ratio of 0.63
| Current Ratio | 0.63 |
| Quick Ratio | 0.14 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.51 |
| Interest Coverage | -1.88 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -7.41% |
| Return on Capital (ROIC) | -13.71% |
| Revenue Per Employee | 1.53M |
| Profits Per Employee | -56,436 |
| Employee Count | 39 |
| Asset Turnover | 4.71 |
| Inventory Turnover | 10.83 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.14% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -57.14% |
| 50-Day Moving Average | 0.72 |
| 200-Day Moving Average | 0.92 |
| Relative Strength Index (RSI) | 36.39 |
| Average Volume (20 Days) | 60 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Arzneiwerk AG VIDA had revenue of EUR 59.68 million and -2.20 million in losses. Loss per share was -0.35.
| Revenue | 59.68M |
| Gross Profit | 3.58M |
| Operating Income | -1.50M |
| Pretax Income | -2.30M |
| Net Income | -2.20M |
| EBITDA | -776,425 |
| EBIT | -1.50M |
| Loss Per Share | -0.35 |
Balance Sheet
The company has 1.08 million in cash and 11.62 million in debt, giving a net cash position of -10.53 million.
| Cash & Cash Equivalents | 1.08M |
| Total Debt | 11.62M |
| Net Cash | -10.53M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -4.97M |
| Book Value Per Share | -0.80 |
| Working Capital | -5.37M |
Cash Flow
In the last 12 months, operating cash flow was -2.54 million and capital expenditures -41,000, giving a free cash flow of -2.58 million.
| Operating Cash Flow | -2.54M |
| Capital Expenditures | -41,000 |
| Free Cash Flow | -2.58M |
| FCF Per Share | n/a |
Margins
Gross margin is 6.00%, with operating and profit margins of -2.52% and -3.69%.
| Gross Margin | 6.00% |
| Operating Margin | -2.52% |
| Pretax Margin | -3.85% |
| Profit Margin | -3.69% |
| EBITDA Margin | -1.30% |
| EBIT Margin | -2.52% |
| FCF Margin | n/a |
Dividends & Yields
Arzneiwerk AG VIDA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -57.88% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on July 10, 2020. It was a reverse split with a ratio of 0.125.
| Last Split Date | Jul 10, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.125 |
Scores
Arzneiwerk AG VIDA has an Altman Z-Score of 1.31. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.31 |
| Piotroski F-Score | n/a |